J Korean Ophthalmol Soc.  2008 Mar;49(3):396-400. 10.3341/jkos.2008.49.3.396.

Evisceration for Intractable Endogenous Endophthalmitis

• Huh YS
• Chung HS
• Son JH

• KMID: 2211308
• DOI: http://doi.org/10.3341/jkos.2008.49.3.396

Abstract

PURPOSE: To evaluate the clinical aspects of severe endogenous endophthalmitis requiring evisceration,particularly underlying disease, causative microorganisms, and infection focus, and to assess the outcome of evisceration.
METHODS
The records of 13 patients who were diagnosed with endogenous endophthalmitis requiring evisceration and treated at Yeungnam University Hospital from July 1994 to April 2007 were retrospectively reviewed.
RESULTS
Of the 13 patients, all patients had diabetes mellitus, five had advanced liver disease, and one had aplastic anemia. Infection foci were pyelonephritis, pneumonia, and liver abscess. Five cases were confirmed with positive culture of lebsiella pneumoniae. Ten cases underwent evisceration with hydroxyapatite implantation, and three cases were treated conservatively because the patient was in poor systemic condition. Of the 10 patients who underwent evisceration, ocular implants were exposed in five cases.
CONCLUSIONS
This study suggests that evisceration with primary orbital implant insertion for endogenous endophthalmitis involves the risk of implant exposure, but after secondary repair, all patients have stable clinical courses.

Keyword

Endogenous endophthalmitis; Evisceration; Primary orbital implant insertion

MeSH Terms

Anemia, Aplastic
Diabetes Mellitus
Durapatite
Endophthalmitis
Humans
Liver Abscess
Liver Diseases
Orbital Implants
Pneumonia
Pyelonephritis
Retrospective Studies
Durapatite

Reference

References

1. Farber BP, Weinbaum DL, Dummer JS. Metastatic Bacterial Endophthalmitis. Arch Intern Med. 1985; 145:62–4.

2. Okada AA, Johnson RP, Liles WC, et al. Endogenous bacterial endophthalmitis. Report of a ten-year retrospective study. Opthalmology. 1994; 101:832–8.

3. Kostick DA, Foster RE, Lowder CY, et al. Endogenous endophthalmitis caused by candida albicans in a healthy woman. Am J Ophthalmol. 1992; 113:593–5.

4. Daily MJ, Dickey JB, Packo KH. Endogenous Candida Endophthalmitis After Intravenous Anesthesia with Propofol. Arch Ophthalmol. 1991; 109:1081–4.

5. Sugar HS, Mandell GH, Shalev J. Metastatic endophthalmitis associated with injection of addictive drug. Am J Ophthalmol. 1971; 71:1055–8.

6. Keswani T, Ahuja V, Changulani M. Evaluation of outcome of various treatment methods for endogenous endophthalmitis. Indian J Med Sci. 2006; 60:454–60.

7. Sohn HJ, Nam DH, Kim YS, Paik HJ. Endogenous aeromonas hydrophila endophthalmitis in an immunocompromised patient. Korean J Ophthalmol. 2007; 21:45–7.

8. Lee SJ, Lee MA, Kwak HW. Clinical aspect of bacterial endogenous endophthalmitis. J Korean Opthalmol Soc. 2000; 41:112–8.

9. La TY, Kim CW, Lee JS. A case of endogenous endophthalmitis accompanying orbital cellulites caused by Klebsiella pneumonia from liver abscess. J Korean Ophthalmol Soc. 2000; 41:1330–4.

10. Shore JW, Dieckert JP, Levine MR. Delayed primary wound closure: use to prevent implant extrusion following evisceration for endophthalmitis. Arch Ophthalmol. 1988; 106:1303–8.

11. Dresner SC, Karesh JW. Primary implant placement with evisceration in patient with endophthalmitis. Ophthalmology. 2000; 107:1661–5.

12. Abel AD, Meyer DR. Enucleation with primary implant insertion for treatment of recalcitrant endopthalmitis and panophthalmitis. Opthal Plast Reconstr Surg. 2005; 21:220–6.

13. Kostick DA, Linberg JV. Evisceration with Hydroxyapatite implant. Surgical technique and review of 31 case reports. Ophthalmology. 1995; 102:1542–9.

14. Son DH, Choi YJ, Ryou JH, Kim SJ. The clinical study of the exposure of implant after evisceration. J Korean Opthalmol Soc. 2004; 45:887–92.